Advertisement Daiichi Sankyo selects research partners for TaNeDS collaborative drug discovery project - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Daiichi Sankyo selects research partners for TaNeDS collaborative drug discovery project

Daiichi Sankyo has selected research partners for its 2015 TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery project.

TaNeDS, which began in 2011 as part of Daiichi Sankyo’s open innovation program, selects researchers from universities and public research centers in Japan, and Daiichi Sankyo will soon begin signing agreements with this year’s selected parties to initiate collaborative research.

Daiichi Sankyo RD Novare (RD Novare), Daiichi Sankyo’s wholly owned subsidiary, joined TaNeDS to promote the development of novel technology platforms for drug discovery from 2013.